Results for tag: "Aimovig"

Aimovig is a central nervous system (CNS) drug used to treat migraine headaches. It is a monoclonal antibody that works by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is involved in the onset of migraine headaches. Aimovig is administered as a once-monthly subcutaneous injection and is the first and only FDA-approved CGRP inhibitor for the prevention of migraine headaches. It is approved for use in adults who experience four or more migraine days per month. The Aimovig market is composed of a variety of companies that are involved in the development, manufacture, and distribution of the drug. These companies include Amgen, Novartis, Teva Pharmaceuticals, and Eli Lilly. Additionally, there are a number of generic drug manufacturers that produce generic versions of Aimovig. Show Less Read more